Insys Wants Out Of Off-Label Fentanyl Prescription Suit
Insys Therapeutics Inc. has urged an Arizona federal court to toss a suit from several Blue Cross Blue Shield Association units that have accused Insys of bribing physicians to write off-label...To view the full article, register now.
Already a subscriber? Click here to view full article